Africa
For more than 25 years, we have worked alongside national governments, local organizations, and other partners in support of their goals for change in Africa.
Featured Stories in Africa
-

A mother’s mission to prevent spina bifida in Ethiopia
From hospital corridors to policy discussions, an Ethiopian mother is making families’ voices heard and advancing efforts to prevent birth defects.
Follow us:
We are partners in saving lives, tackling infectious diseases, and lifting people out of poverty across Africa
Focus countries

South Africa
We work with partners in South Africa to advance research and solutions that address the country’s areas of greatest need, including HIV and tuberculosis prevention, diagnosis, and treatment and progress in gender equality.

Kenya
In Kenya, our work focuses on areas of overlap between our expertise and the government’s priorities under the Kenya Vision 2030 development blueprint and the country’s United Nations Sustainable Development Goals, which include primary health care and gender equality.

Nigeria
Since opening our office in Abuja in 2012, we have worked closely with partners in Nigeria to make progress in key areas of health, including primary health care and polio eradication.

Senegal
Our work in Senegal focuses on areas of overlap between our expertise and the government’s priorities under the country’s 2025–2029 national development strategy and the Senegal 2050 vision.

Ethiopia
Since opening our office in Addis Ababa in 2012, we have partnered with the Ethiopian government, donors, the private sector, and civil society organizations to help improve agricultural productivity and increase the coverage of life-saving health and nutrition interventions.
At a glance
- We focus on countries where we believe we can have the greatest impact.
- We support a range of programs that work to improve health and nutrition; gender equality; disease prevention, treatment, and research; water, sanitation, and hygiene; agriculture; and financial services for the poor.
Get the Optimist newsletter
Join 300,000 readers who see the world differently. Subscribe for hopeful stories about the people and partnerships improving lives around the world — every other week.
By submitting your email to subscribe, you agree to the Gates Foundation’s
Privacy & Cookies Notice.
Latest grants
-
World Health Organization Regional Office for Africa
View grantee: World Health Organization Regional Office for Africa -
Izuba Education Partners Limited
View grantee: Izuba Education Partners Limited -
Matahari Global Solutions Sdn Bhd
View grantee: Matahari Global Solutions Sdn Bhd -
Redeemer’s University LTD/GTE
View grantee: Redeemer’s University LTD/GTE -
Christian Connections for International Health
View grantee: Christian Connections for International Health -
Fenot Associates Social Services PLC
View grantee: Fenot Associates Social Services PLC
FAQ
Browse all FAQ
Frequently Asked Questions below
An estimated 218 million women in low- and middle-income countries still have an unmet need for modern contraception, and the United Nations estimates that 19% of women in sub-Saharan Africa have an unmet contraceptive need.
When women and girls have access to contraceptives and health services they want and need, they’re able to make informed reproductive decisions and are more empowered to live their lives as they choose. Women and girls who have agency over their health can reach their full potential—more girls can go to school, and more women can work outside the home. Those choices also contribute to healthier pregnancies and safer births, meaning more newborns can thrive and have a chance at a productive future.
We focus on helping women and girls access the health services and products, including family planning, that align with their preferences—ones that are affordable, convenient, and culturally appropriate. We also support efforts that improve how family planning services are delivered and improving health systems to meet the needs of women and girls.
Our commitment will support the advancement of more than 40 innovations in five critical and chronically underfunded areas, particularly those affecting women in low- and middle-income countries. This investment includes:
- Obstetric care and maternal immunization: Making pregnancy and delivery safer
- Maternal health and nutrition: Supporting healthier pregnancies and newborns
- Gynaecological and menstrual health: Advancing tools and research to better diagnose, treat, and improve gynaecological health and reduce infection risk
- Contraceptive innovation: Offering more accessible, acceptable, and effective options
- Sexually transmitted infections (STIs): Improving diagnosis and treatment to reduce disproportionate burdens on women
Gene drive is part of a growing field of genetically based vector control (GBVC) tools scientists are exploring to help stop the spread of malaria. It works by changing the genes of malaria-carrying mosquitos so they either can’t pass on the disease or their numbers go down over time. These changes are designed to pass through future generations of mosquitoes, which gives gene drive the potential for long-term impact.
Importantly, it only targets malaria-carrying species, leaving others untouched. In remote areas most impacted by malaria, gene drive could be a breakthrough, offering inexpensive and sustainable protection that doesn’t depend on people taking medicines or the constant delivery of supplies.
Not all genetically modified mosquitoes use gene drive technology. Other types target male mosquitoes and are engineered to pass down “self-limiting” genes to prevent their offspring from surviving to adulthood. Unlike gene drive, these traits do not last long in the mosquito population and require repeated releases of mosquitoes.
Genetically based vector control research is being conducted by scientists and global partners in countries most burdened by malaria under strict safety and regulatory oversight. All decisions about the approval of the technology are made by national regulatory bodies, following strict national laws and international guidelines.
Malaria kills nearly 600,000 people each year, mostly African children. Current tools have helped achieve significant progress—but they aren’t enough to eradicate malaria. New challenges like drug and insecticide resistance and climate change threaten existing progress. Gene drive technology could provide long-lasting, self-sustaining protection without relying on human behavior or complex delivery systems, making it particularly valuable for reaching remote, underserved communities.
Since no single tool can eradicate malaria alone, gene drive is being developed by Africa scientists as part of a several interventions including next-generation bed nets, spatial repellents, next-generation vaccines, long-acting chemoprevention, and sophisticated monitoring tools. Using multiple tools and technologies to address malaria helps countries break the cycle of illness, poverty, and death linked to the disease.
Disease outbreaks can threaten lives, disrupt livelihoods, and place enormous pressure on health systems. The Gates Foundation supports partners working to help countries detect and respond to health threats earlier and more effectively.
Read the foundation’s FAQ about outbreak preparedness and response →
Our major partners in Africa
Leadership
Our leaders are guided by the foundation’s mission to create a world in which every person has the opportunity to live a healthy, productive life.
More about the region
Regional offices
We work across Africa from our regional headquarters in Johannesburg and our offices in Abuja, Addis Ababa, Dakar, and Nairobi.
Working with us
Find out about our values, see the benefits we offer, view employee profiles, and search for open positions.
Connect with us
Use the links below to contact us or follow our work.





















